Arvinas (ARVN) 10-Q2024 Q3 Quarterly report

Filed: 30 Oct 24, 5:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: ABC, Agency, anniversary, ascending, baseline, BCL, Biennial, blinded, blood, Burkitt, castration, cell, center, cerebrospinal, chemotherapy, circulating, collagen, College, comprising, concurrently, count, CSF, ctDNA, cycle, damage, description, Detailed, DLBCL, DOR, driver, encouraging, enlargement, experimental, expression, febrile, fluid, found, Fox, fraction, GCB, gene, germinal, Hematology, highlighted, HSR, II, inflammation, input, interaction, kirsten, label, lung, lysosomal, meaningfully, Michael, midazolam, murine, narrowly, neutropenia, newly, NHL, NR, oncogene, ORR, pathologic, percentage, PFS, pioneering, pneumocyte, poor, poster, prescribing, primate, proliferation, pulmonary, rapid, rapidly, rat, recombination, recruiting, regression, release, repeat, repressing, repressor, sarcoma, session, somatic, Street, suggesting, surfactant, sustained, tau, tauopathy, timeline, transcriptional, transfer, type, unchanged, white, wind, Yale

Removed: account, addressed, annually, build, collectively, dispute, extensive, higher, improvement, intracellular, linked, March, modification, moving, reach, resolution, tenant, unmet

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated ARVN transcripts

ARVN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Arvinas, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date: October 30, 2024	By:	/s/ Andrew Saik
		Andrew Saik Chief Financial Officer and Treasurer (Principal Financial Officer)